CD279 (Programmed cell death protein 1 (PD-1) is a molecule that reduces T cell activity and is often increased in tumor environments.
CD279 (Programmed cell death protein 1 (PD-1) is a coinhibitory receptor found on T cells and other immune cells. Its ligands, CD274 (Programmed death-ligand 1 (PD-L1) and CD273 (Programmed cell death 1 ligand 2 (PD-L2), bind to CD279 (Programmed cell death protein 1 (PD-1), leading to impaired T cell function in cancer and chronic infections.
CD279 (Programmed cell death protein 1 (PD-1) is a member of the CD28 family, and is responsible for the dysfunction of T cells / T lymphocytes in infectious diseases and cancers.
Programmed cell death protein 1 (PD-1) is an inhibitory cell-surface Immune Checkpoint Receptors expressed on several immune cells (e.g., activated T cells: CD4 +, Regulatory T cells), particularly [CTL], B cells / B Lymphocytes, NKT cells, monocytes, dendritic cells(?id=9a33b79a-98e3-435f-b3bb-dc8be1d4960d&linkText=CTL)
Programmed death 1 (PD-1) and its ligands, PD-L1 and PD-L2, deliver inhibitory signals that regulate the balance between T cell activation, tolerance, and immunopathology.
Programmed cell death protein 1 (PD-1) is a receptor of the Ig superfamily that negatively regulates T cell antigen receptor signaling by interacting with the specific ligands (PD-L).
Programmed cell death protein 1 (PD-1) is an immuno-inhibitory receptor expressed by activated T cells, B cells / B Lymphocytes, and myeloid cells.
Mice deficient in Programmed cell death protein 1 (PD-1) exhibit a breakdown of peripheral tolerance and demonstrate multiple autoimmune features.
Engagement of Programmed cell death protein 1 (PD-1) by Programmed death-ligand 1 (PD-L1) leads to the inhibition of T cell receptor-mediated lymphocyte proliferation and cytokine secretion.